The health-care industry requires large expenditure on research and development (R&D), with many projects undergoing long development cycles, usually with uncertain outcomes. Extant research has mainly concentrated on the health-care industry in the United States, where R&D costs are expensed as...

This paper demonstrates that (time- and context-specific) ‘political costs' were instrumental in the entry of deferred tax accounting into Australian GAAP in the early 1970's—a period in which high profits and low corporate taxes coincided in a volatile political mix. Politically...

We investigate the valueâ€relevance of capitalised R&D on the balance sheet, and the extent to which R&D accruals improve the association between accountingâ€based measures of firm perfor Mance and capital market returns for Australian listed companies. This is a regulatory setting where...